Search Results for "Mesalazine Diverticulosis"
Original Source: Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease
Diverticulosis (bulges in the bowel wall) affects two third of the elderly population in the UK. Diverticular disease and its complications are responsible for 68000 hospital admissions and 2000 deaths per year. It commonly produces recurrent short lived abdominal pain, changes in bowel habit and incontinence. The causes of symptoms are not known and the treatments unsatisfactory. Recent studies have found an association between inflammation, alteration of bowel nerves and symp...
Matching Channels
Ulcerative colitis is a disease that affects around 120,000 people in the UK and causes inflammation of the large intestine - or colon. Symptoms vary in severity from pain and discomfort, through mu...
Matching News
Scientist Claims New Fiber Could Cut Risk of Crohn's Disease
A Purdue University scientist trying to solve a general digestive problem ended up creating a new type of fiber. He believes its use might improve overall digestive health and cut the risk of developi...
Mesalazine an Option for Diverticular Disease
Mesalazine, an anti-inflammatory long used to treat inflammatory bowel disease, has shown promise as a treatment for uncomplicated diverticular disease in a placebo-controlled study. Reuters Health...
HEIDELBERG, Germany, April 10, 2013 /PRNewswire/ -- IND paves the way for the US element of a global Phase III development program with LT-02 in conjunction with European licensee Dr. Falk Pharma Gmb...
[Ferring] gets rights to [Albireo]'s elobixibat
Swedish gastrointestinal-focused start-up [Albireo AB] has licensed Swiss firm [Ferring Pharmaceuticals AS] (therapies for reproductive health, urology, gastroenterology, and endocrinology) worldwide...
Ferring Pharmaceuticals Acquires Licensing Rights for Elobixibat from Albireo AB
Ferring Pharmaceuticals (Ferring) and Albireo AB (Albireo) announced today that they have signed a license agreement under which Ferring has rights to develop and commercialise el...
Deals Of The Week: A New Sound For The Fourth Of July
Certain sounds signify the Fourth of July season in the U.S. – the pop and boom of fireworks, the sizzle of burgers and hot dogs on the grill, the crack of the bat as baseball reaches mid-season. An...
Matching PubMed Articles
Background Different oral formulations of 'mesalazine (mesalamine)' may have different efficacy in distal ulcerative colitis. Aim To evaluate the efficacy of mesalazine granules (Salofalk granule...
Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies.
Colonic diverticular disease is common in Western countries and its prevalence increases with age. The large majority of patients (80-85%) will remain entirely asymptomatic throughout their life. In s...
Clinical significance of colonic diverticulosis associated with bowel symptoms and colon polyp.
This study was done to evaluate prospectively the clinical significance of colonic diverticulosis. In the 1,030 consecutive outpatients undergoing colonoscopy, the information on the demographics, the...
BACKGROUND: Aminosalicylates are first-choice treatment for mild-to-moderately active ulcerative colitis (UC); however, multi-dosing regimens are inconvenient. AIM: To compare the efficacy and safety...
PURPOSE: Mesalazine and sulfasalazine are commonly used drugs for the treatment of inflammatory bowel disease. However, there have been few reports with a strict statistical analysis comparing the eff...
